The expression levels of p53 and EGFR in stage I+II NPC were significantly lower than that in stages III+IV (p53: χ2,4.809; P=0.037; EGFR: χ2, 15.128; P=0.001). Here, TP53 is linked to nasopharyngeal carcinoma.